Literature DB >> 6373928

Mononuclear cell-mediated enhancement of granulocyte function in man.

M A Vadas, N Nicola, A F Lopez, D Metcalf, G Johnson, A Pereira.   

Abstract

Human monocyte-enriched mononuclear cells (MNC) (greater than 95% monocytes) powerfully stimulated the antibody-dependent killing of tumor cells by purified human neutrophils (NE) or eosinophils (EO). The enhancement was observed when the mononuclear cell to granulocyte ratio was as low as 1:100. Media conditioned by MNC also stimulated antibody-dependent killing by NE and EO as well as the uptake and killing of Candida albicans by NE. There was a heterogeneity amongst individuals in the capacity of their MNC to elaborate this factor, and approximately 15% of individuals did not produce detectable factor. Different factors in the MNC supernatant were involved in NE and EO activation. The EO-activating factor (AF) had a m.w. of approximately 27,000 and migrated as a single band on phenyl-Sepharose chromatography. The NE-AF had a m.w. of 22,000 and migrated as two distinct bands on phenyl-Sepharose chromatography. EO-colony-stimulating factor (CSF) co-purified with EO-AF, and granulocyte-macrophage-CSF co-purified with both bands of NE-AF. It is concluded that MNC elaborate CSF-like molecules that powerfully stimulate human granulocyte function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6373928

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Granulocyte-macrophage colony-stimulating factor augments neutrophil killing of Torulopsis glabrata and stimulates neutrophil respiratory burst and degranulation.

Authors:  I C Kowanko; A Ferrante; D P Harvey; K L Carman
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

2.  Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes.

Authors:  A Siegbahn; A Hammacher; B Westermark; C H Heldin
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 3.  Eosinophils. Assays and interpretation.

Authors:  D E Maddox
Journal:  Clin Rev Allergy       Date:  1988

4.  Peripheral blood and intrarenal phagocytic chemiluminescence during acute kidney graft rejection.

Authors:  F Schödel; F Krombach; C Hammer; W Brendel
Journal:  Inflammation       Date:  1986-09       Impact factor: 4.092

5.  The effects of eosinophil activating factor on IgG-dependent sulphidopeptide leukotriene generation by human eosinophils.

Authors:  P Fitzharris; R Moqbel; K J Thorne; B A Richardson; A Hartnell; O Cromwell; A E Butterworth; A B Kay
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

Review 6.  New properties and roles for eosinophils in disease: discussion paper.

Authors:  C J Spry
Journal:  J R Soc Med       Date:  1985-10       Impact factor: 5.344

7.  Enhancement of leukotriene C4 release from primate airway macrophages by cellular interactions.

Authors:  A M Campbell; S T Harper; C Hallam; E Wells; J Mann; C Robinson
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

8.  Stimulation of neutrophil respiratory burst and lysosomal enzyme release by human interferon-gamma.

Authors:  I C Kowanko; A Ferrante
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

9.  Patients with renal cancer have a larger proportion of high-density blood monocytes with increased lucigenin-enhanced chemiluminescence.

Authors:  A Trulson; S Nilsson; E Brekkan; P Venge
Journal:  Inflammation       Date:  1994-02       Impact factor: 4.092

10.  Fungicidal activity of murine inflammatory polymorphonuclear neutrophils: comparison with murine peripheral blood PMN.

Authors:  E Brummer; J G McEwen; D A Stevens
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.